PMC:7311890 / 528-720
Annnotations
LitCovid_Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 46-76 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | monosialodihexosyl ganglioside |
| T2 | 78-81 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
| T3 | 78-81 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T3 | 0-6 | Body_part | denotes | Plasma | http://purl.org/sig/ont/fma/fma62970 |
| T4 | 65-76 | Body_part | denotes | ganglioside | http://purl.org/sig/ont/fma/fma82816 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T6 | 19-27 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 0-6 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | Plasma |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T2 | 46-76 | Chemical | denotes | monosialodihexosyl ganglioside | http://purl.obolibrary.org/obo/CHEBI_84118 |
| T3 | 65-76 | Chemical | denotes | ganglioside | http://purl.obolibrary.org/obo/CHEBI_28892 |
| T4 | 78-81 | Chemical | denotes | GM3 | http://purl.obolibrary.org/obo/CHEBI_15681|http://purl.obolibrary.org/obo/CHEBI_84118 |
| T6 | 126-140 | Chemical | denotes | sphingomyelins | http://purl.obolibrary.org/obo/CHEBI_17636|http://purl.obolibrary.org/obo/CHEBI_62490 |
| T8 | 142-145 | Chemical | denotes | SMs | http://purl.obolibrary.org/obo/CHEBI_17636 |
| T9 | 169-184 | Chemical | denotes | diacylglycerols | http://purl.obolibrary.org/obo/CHEBI_18035 |
| T10 | 186-190 | Chemical | denotes | DAGs | http://purl.obolibrary.org/obo/CHEBI_18035 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 27 | 46-76 | Chemical | denotes | monosialodihexosyl ganglioside | |
| 28 | 78-81 | Chemical | denotes | GM3 | |
| 29 | 126-140 | Chemical | denotes | sphingomyelins | MESH:D013109 |
| 30 | 142-145 | Chemical | denotes | SMs | MESH:D013109 |
| 31 | 151-155 | Chemical | denotes | GM3s | |
| 32 | 169-184 | Chemical | denotes | diacylglycerols | MESH:D004075 |
| 33 | 186-190 | Chemical | denotes | DAGs | MESH:D004075 |
| 40 | 19-27 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 0-192 | Sentence | denotes | Plasma lipidome of COVID-19 resembled that of monosialodihexosyl ganglioside (GM3)-enriched exosomes, with enhanced levels of sphingomyelins (SMs) and GM3s, and reduced diacylglycerols (DAGs). |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T11 | 0-6 | UBERON:0001969 | denotes | Plasma |
| T12 | 19-27 | SP_7 | denotes | COVID-19 |
| T13 | 65-76 | CHEBI:24195;CHEBI:24195 | denotes | ganglioside |
| T14 | 92-100 | GO:0070062 | denotes | exosomes |
| T15 | 126-140 | CHEBI:64583;CHEBI:64583 | denotes | sphingomyelins |
| T16 | 151-155 | PR:000015682 | denotes | GM3s |
| T17 | 169-184 | CHEBI:18035;CHEBI:18035 | denotes | diacylglycerols |
| T18 | 186-190 | CHEBI:18035;CHEBI:18035 | denotes | DAGs |
| T25314 | 0-6 | UBERON:0001969 | denotes | Plasma |
| T13014 | 19-27 | SP_7 | denotes | COVID-19 |
| T73199 | 65-76 | CHEBI:24195;CHEBI:24195 | denotes | ganglioside |
| T82491 | 92-100 | GO:0070062 | denotes | exosomes |
| T3559 | 126-140 | CHEBI:64583;CHEBI:64583 | denotes | sphingomyelins |
| T50733 | 151-155 | PR:000015682 | denotes | GM3s |
| T34334 | 169-184 | CHEBI:18035;CHEBI:18035 | denotes | diacylglycerols |
| T71152 | 186-190 | CHEBI:18035;CHEBI:18035 | denotes | DAGs |